Table 2 Overall and Progression Free Survival (All patients)
Cohort A (No Metformin) | Cohort B (Metformin) |
|---|---|
Overall Survival | |
 • 67.7% patients alive at 1 year | • 88.2% patients alive at 1 year |
 • 62.0% patients alive at 2 years | • 73.3% patients alive at 2 years |
 • 20.7% patients alive at 3 years | • 73.3% patients alive at 3 years |
Progression Free Survival | |
 • 36.6% patients free from progression at 1 year | • 56.1% patients free from progression at 1 year |
 • 31.3% patients free from progression at 2 years | • 49.1% patients free from progression at 2 years |